LNK suppresses interferon signaling in melanoma
LNK is a tumor suppressor in hematopoietic cancers, but its function in melanoma is unclear. Here, the authors show that the overexpression of LNK in melanomas correlate with hyperactive signaling of the RAS-RAF-MEK pathway and LNK enhances melanoma growth and survival and immune evasion by inhibiti...
Guardado en:
Autores principales: | Ling-Wen Ding, Qiao-Yang Sun, Jarem J. Edwards, Lucia Torres Fernández, Xue-Bin Ran, Si-Qin Zhou, Richard A. Scolyer, James S. Wilmott, John F. Thompson, Ngan Doan, Jonathan W. Said, Nachiyappan Venkatachalam, Jin-Fen Xiao, Xin-Yi Loh, Maren Pein, Liang Xu, David W. Mullins, Henry Yang, De-Chen Lin, H. Phillip Koeffler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/87746954caf641c38aaf967ff326924d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Fanconi anemia
por: Joanna Balcerek, et al.
Publicado: (2018) -
Regression of nevi in a melanoma patient treated with interferon
por: Ayelet Rishpon, et al.
Publicado: (2012) -
Influence of genetic variants in type I interferon genes on melanoma survival and therapy.
por: Romina Elizabeth Lenci, et al.
Publicado: (2012) -
Long-term pegylated interferon-α and its potential in the treatment of melanoma
por: Reinhard Dummer, et al.
Publicado: (2009) -
Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
por: Chuanliang Cui, et al.
Publicado: (2021)